Tolevamer
Navigation Links
Tolevamer in Medical News
Genzyme Announces First Phase III Study of Tolevamer in Diarrhea Patients
Genzyme Corp. announced top-line data from the first of two Phase 3 clinical studies to assess the safety and efficacy of tolevamer liquid, an investigational, non-antibiotic , polymer therapy for patients with Clostridium difficile associated diarrhea (CDAD). The second Phase 3 study of tolevamer ...Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year
...in May and June 2006. (9) Includes charges totaling $(5,735)K recorded in December 2007 to write off costs associated with the manufacture of tolevamer at our manufacturing facilities in Ireland and the United Kingdom. (10) All periods except for the three months and year ended December 31, ...Tolevamer in Medical Technology
CAMBRIDGE, Mass., July 06, 2007 /PRNewswire-FirstCall/ --
Genzyme Corp. announced top-line data today from the first of two
Phase 3 clinical studies to assess the safety and efficacy of
tolevamer liquid, an investigational, non-antibiotic, polymer
therapy for patients with Clostridium difficile as...
Tolevamer in other areas
Tolevamer - Wikipedia, the free encyclopedia
Tolevamer is a toxin binding polymer that was investigated by Genzyme for the treatment of Clostridium difficile associated diarrhoea (CDAD).Results Published of Phase 2 Study of Tolevamer for C. difficile ...
Tolevamer is a novel therapy that could be the first non-antibiotic treatment ... Tolevamer is designed to bind and remove from the body toxins released by C. ...Genzyme's diarrhea drug Tolevamer fails trial | Reuters
NEW YORK (Reuters) - Genzyme Corp. <GENZ.O> said on Friday its experimental drug tolevamer, a treatment for diarrhea associated with the intestinal infection ...Tolevamer Fails in Phase 3 Diarrhea Trial: Presented at ICAAC
Genzyme is developing tolevamer and sponsored the trial. ... Patients in the tolevamer group received a 9-g loading dose on the first day. ...Genzyme Treatment Fails Against Antibiotic in a Study (Update5 ...
The company had considered tolevamer one of its most-promising products, ... The results for tolevamer compared the drug with the antibiotic vancomycin, the ...Genzyme's Pipeline Hits a Snag - Morningstar Stock Analyst Notes
Genzyme's Pipeline Hits a Snag - <P>Genzyme <a href=http://quote.morningstarOther TagsPrecPrecPrecPrecPrecPrecAPOAPOAPOAPOAPOAPOOther Contentsconservedconservedconservedconservedconservedconservedconservedevolutionarilyevolutionarilyevolutionarilyevolutionarilyexocrineexocrineexogenousexogenousexogenousexogenousexogenousexogenousexonsexonsexonsexonsexoskeletonexoskeletonexonucleaseexonucleaseexonucleaseexpressexpressexpressexpressexpressexpressexpressexpress
(Date:11/26/2009)... Dr. David Kim of the Live Life Aga...y in Dallas , is one of a growing number of physic...etworking sites to connect with individuals who ar...fight morbid obesity. Dr. Kim is utilizing Faceboo... about his practice with the community. , ...
(Date:11/26/2009)... Benton Communications announces a ...h system for retailers struggling to make an econo...ovember 26, 2009 -- Flu fears is the type of chall...mergency room, according to Dr. David Benton, busi...d business growth system – The Rfactor Inte...
(Date:11/25/2009)..., EDINA, Minn., Nov. 25 ... of their dentist. But a chiropractor can also gi... Temporal-Mandibular Joint, which is where your ja...mporal bone). ,, The most common symptoms asso... clicking or popping of the jaw. But many other s...
(Date:11/25/2009)..., EMERYVILLE, Calif., Nov. 25 /PRNewswire-FirstC...X ) today announced that the company will host two... ,, December 7, 2009 - 9:00 a.m. CT/10:00 ...ss data presentations surrounding carfilzomib in r...tured at the 51st American Society of Hematology (...
(Date:11/25/2009)..., TORONTO, Nov. 25 /PRNewswire/ - Sentinelle Medic...s and advanced visualization software launches a s...its Aegis(TM) medical imaging software platform at... (RSNA) annual meeting in Chicago, Nov. 30 - Dec. ...erage the unique high quality images generated by ...
Breaking Medicine News(10 mins):Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 4[1] Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients[1] Pharmacist Injects Cure for Ailing Businesses [1] TMJ and Chiropractic Care: An Overall Wellness Approach[0] Onyx Pharmaceuticals Announces December 2009 Investor Events[1] Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology
(Date:11/24/2009)...ATON ROUGE Antarctica has long held secrets of th...til recently, there has been very little informati...th miles of ice for millions of years. Now, a team...LSU have been funded to the tune of $10 million d... to get to the bottom of things literally. These ...
(Date:11/23/2009)...hington, D.C. The community-associated strain of ...ria resistant to most common antibioticsposes a fa...is making its way into hospitals, according to a s... Diseases . , The new threat is easily picked u...aces and has increased the overall burden of MRSA ...
(Date:11/23/2009)...mington, CT Current research suggests that a comm...e. The related report by Nichols et al, "Unique L...w Class of TLR2 Ligands Capable of Enhancing Autoi...e American Journal of Pathology . , Multiple sc...tacks the brain and spinal cord, affects nearly 1 ...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2Sinovac Schedules 2008 Annual General Meeting 48447 1Sinovac Schedules 2008 Annual General Meeting 48447 2The University of Miami Miller School of Medicine the City of Miami Microsoft and Resolute Solutions Seek to Improve Care of Diabetic Populations Us 48442 1The University of Miami Miller School of Medicine the City of Miami Microsoft and Resolute Solutions Seek to Improve Care of Diabetic Populations Us 48442 2The University of Miami Miller School of Medicine the City of Miami Microsoft and Resolute Solutions Seek to Improve Care of Diabetic Populations Us 48442 3American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 48437 1American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 48437 2American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 48437 3American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 48437 4| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |